David R. Mottram

2.4k citations
84 papers · 1.8k indexed · 1 hit paper · h-index 20
Topics
Pharmaceutical Practices and Patient Outcomes (19 papers)Receptor Mechanisms and Signaling (15 papers)Pharmacovigilance and Adverse Drug Reactions (14 papers)

In The Last Decade

David R. Mottram

81 papers receiving 1.7k citations

Hit Papers

Adverse Drug Reactions in Hospital In-Patients: A Prospec...20092026201420202009100200300400500

Peers

David R. Mottram
Comparison fields: 5 of 123
  • Toxicology 677
  • Geriatrics and Gerontology 656
  • Pediatrics, Perinatology and Child Health 455
  • Molecular Biology 235
  • Pharmacology 212
Replace Andrew Scott with:
Andrew Scott United Kingdom
Philip A. Routledge United Kingdom
Tom Mjörndal Sweden
Anna K. Jönsson Sweden
Jerry L. Bauman United States
Corinne M. Hohl Canada
Haleh Bagheri France
L. F. Gram Denmark
Janet Sultana Italy
Odd Brørs Norway
David R. Mottram relative to Andrew Scott United Kingdom Andrew Scott's profile →
Citations per field
00.5×1.5×
Andrew Scott · 1×
Citations per year

Countries citing papers authored by David R. Mottram

Since Specialization
Citations

This map shows the geographic impact of David R. Mottram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Mottram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Mottram more than expected).

Fields of papers citing papers by David R. Mottram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Mottram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Mottram. The network helps show where David R. Mottram may publish in the future.

Co-authorship network of co-authors of David R. Mottram

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Mottram. A scholar is included among the top collaborators of David R. Mottram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Mottram. David R. Mottram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2
Perspective of pharmacists in Qatar regarding doping and anti-doping in sports.
12
3 72
4 87
5 28
6 30
7 67
8
DRUGS IN SPORT
8
9
Over-the-counter drug use amongst athletes and non-athletes.
15
10 22
11 20
12 150
13 78
14 54
15 14
16 2
17 44
18 11
19 3
20 16

About David R. Mottram

David R. Mottram is a scholar working on Toxicology, Geriatrics and Gerontology and Cellular and Molecular Neuroscience, having authored 84 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (19 papers), Receptor Mechanisms and Signaling (15 papers) and Pharmacovigilance and Adverse Drug Reactions (14 papers). The work is most often cited by research in Toxicology (677 citations), Geriatrics and Gerontology (656 citations) and Family Practice (61 citations). David R. Mottram has collaborated with scholars based in United Kingdom, United States and Egypt. Frequent co-authors include Munir Pirmohamed, Christopher F. Green, Emma Davies, Stephen Taylor, Paula Williamson, Philip Rowe, P.H. Rowe, Mark Stuart, J. D. Lever and Neil Chester. Their work appears in journals such as PLoS ONE, British Journal of Pharmacology and Sports Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026